Literature DB >> 2438152

Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.

M R Hollingdale, W R Ballou, S B Aley, J F Young, S Pancake, L H Miller, W T Hockmeyer.   

Abstract

The immunodominant epitope region of the circumsporozoite protein of Plasmodium falciparum sporozoites contains 37 tandem repeats of the tetrapeptide Asn-Ala-Asn-Pro and 4 repeats of Asn-Val-Asp-Pro. Synthetic peptides and recombinant proteins of the repeat region were used to immunize mice using different doses and adjuvants. Antisera were tested for inhibition of sporozoite invasion of cultured human hepatoma cells. Synthetic peptides and recombinant proteins elicited high levels of antibodies that inhibited sporozoite invasion when emulsified with complete Freund's adjuvant. Since recombinant proteins with alum elicited a better antibody response to sporozoite invasion than they did without adjuvant, it may be that a recombinant protein containing 32 tandem copies of the tetrapeptide repeat combined with alum could be a candidate malarial vaccine suitable for human trials.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438152     DOI: 10.1016/0014-4894(87)90182-2

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

Review 1.  Malaria vaccines.

Authors:  A A Holder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

2.  Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.

Authors:  Rhea J Longley; Karolis Bauza; Katie J Ewer; Adrian V S Hill; Alexandra J Spencer
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 3.  Current view on novel vaccine technologies to combat human infectious diseases.

Authors:  Zrinka Matić; Maja Šantak
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

Review 4.  Malaria vaccines: identifying Plasmodium falciparum liver-stage targets.

Authors:  Rhea J Longley; Adrian V S Hill; Alexandra J Spencer
Journal:  Front Microbiol       Date:  2015-09-15       Impact factor: 5.640

5.  A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

Authors:  Alison Roth; Steven P Maher; Amy J Conway; Ratawan Ubalee; Victor Chaumeau; Chiara Andolina; Stephen A Kaba; Amélie Vantaux; Malina A Bakowski; Richard Thomson-Luque; Swamy Rakesh Adapa; Naresh Singh; Samantha J Barnes; Caitlin A Cooper; Mélanie Rouillier; Case W McNamara; Sebastian A Mikolajczak; Noah Sather; Benoît Witkowski; Brice Campo; Stefan H I Kappe; David E Lanar; François Nosten; Silas Davidson; Rays H Y Jiang; Dennis E Kyle; John H Adams
Journal:  Nat Commun       Date:  2018-05-09       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.